Consistently, transfer of activated CD8+ T cells with A2ARi plus Lip-1 resulted in a greater inhibition of tumor growth (Figure 4P) and a longer overall survival (Figure 4Q) of hosts than those with each treatment alone. This evidence concerns the gene CD8A and neoplasm.